ACE-031

ACE-031 is a recombinant fusion protein that combines the extracellular domain of the activin receptor type IIB (ActRIIB) with the Fc region of immunoglobulin G1 (IgG1). This innovative compound is primarily investigated for its ability to inhibit myostatin and related ligands, which are known to play significant roles in muscle growth regulation and bone metabolism.

Research involving ACE-031 focuses on its potential to enhance muscle mass and strength by blocking the activity of myostatin, a negative regulator of muscle growth. By interfering with the signaling pathways of myostatin, ACE-031 may promote muscle hypertrophy and improve overall muscle function. Additionally, studies have explored its implications in bone metabolism, suggesting that it may have beneficial effects on bone density and health.

Due to its unique mechanism of action, ACE-031 is a valuable tool for researchers studying muscle-wasting conditions, age-related muscle loss, and potential therapeutic strategies for enhancing muscle and bone health. Its application in preclinical research continues to provide insights into the biological processes governing muscle and bone metabolism.

For research and laboratory use only. Not for human consumption.